市场调查报告书

全球肘关节置换术市场:各手术类型、终端用户、地区 - 成长,趋势,预测(2018年~2023年)

Elbow Replacement Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 648669
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
全球肘关节置换术市场:各手术类型、终端用户、地区 - 成长,趋势,预测(2018年~2023年) Elbow Replacement Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日内容资讯: 英文 120 Pages
简介

全球肘关节置换术市场,预计从调查期间的2018年到2023年以良好的步调成长。肘关节置换术,是除去损伤的部位替换为人工关节的手术。主要是推荐给肘关节风湿患者的治疗方法,不过,上臂骨远位部骨折和其他肘的病例也可适用。

本报告提供全球肘关节置换术市场调查,市场概要,各手术类型、终端用户、地区的市场趋势,市场规模的变化与预测,成长要素、阻碍因素以及市场机会、课题分析,竞争情形,主要企业的简介等系统性资讯。

目录

第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要

  • 目前市场方案
  • 波特的五力分析
    • 买方议价能力
    • 供给企业谈判力
    • 新加入业者的威胁
    • 替代品的威胁
    • 竞争企业间的敌对关系

第6章 成长要素,阻碍因素,市场机会,课题分析(DROC)

  • 成长要素
    • 肘关节炎的罹患数的增加
    • 肘部位的损伤数量的增加
    • 不动身体的生活
  • 阻碍因素
    • 替代治疗方法的存在
    • 治疗费
  • 市场机会
  • 主要课题

第7章 全球肘关节置换术市场:各市场区隔

  • 各手术类型
    • 肘关节部分置换术
    • 肘全人工关节置换术
  • 各终端用户
    • 医院
    • 整形外科中心
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第8章 竞争情形

  • 合并、收购分析
  • 协定、联盟、合作
  • 新产品的上市

第9章 主要企业的简介

  • Biomet Inc.
  • De Puy Synthes
  • Lima Corporate
  • Ottobock Healthcare
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Holdings Inc.

第10章 市场未来展望

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 57310

The damaged parts of the elbow are replaced with artificial elbow devices through a surgery which is known as elbow replacement. The growth is mainly driven by technological advancements and the growing burden of diseases such as osteoarthritis and rheumatoid arthritis. Elbow replacement can also be extended to cases, such as distal humerus fractures, distal humerus nonunions, and other elbow injuries. Rheumatoid Arthritis (RA) is a chronic systemic disease that affects the joints, connective tissues, muscle, tendons, and fibrous tissue. According to John Hopkins Research, the prevalence of rheumatoid arthritis is 1% to 2% globally, and the important joints involve wrist and elbow. Furthermore, the global increase in the number of geriatrics is likely to lead to consequences, like greater incidences of chronic and life-threatening diseases. Thus, the increasing disease burden of arthritis is expected to drive the elbow replacement market.

Key Market Trends

Total Elbow Replacement Segment is Expected to Show Better Growth in the Forecast Years

Based on the product, it is segmented into partial elbow replacement and total elbow replacement. In total elbow replacement surgery, the damaged parts of the humerus and ulna are replaced with artificial components. The segment is anticipated to grow at a significant rate due to an increase in the number of patients, advancing technologies, and rising prevalence of arthritis. As per the Centers for Disease Control and Prevention (CDC), in 2014, around 54 million U.S. adults had doctor-diagnosed arthritis. Arthritis is the leading cause of disability, stiffness, and swelling of the joints, which usually occurs in older people, resulting in a high demand for elbow replacement surgeries. Pertaining to these factors, the market is expected to grow over the forecast period.

North America Dominates the Elbow Replacement Market

The elbow replacement market dominates North America due to a sedentary lifestyle, the growing burden of rheumatoid arthritis and elbow injuries. According to World Health Organization, the prevalence of rheumatoid arthritis varies between 0.3% and 1% and is more common in women and in developed countries. According to a study published in 2016, in the United States, there is an increase in the number of total elbow arthroplasty procedures performed per year, which is expected to drive the market growth. Furthermore, advanced technology, rise in awareness among people toward extremities implants, and developed healthcare infrastructure are estimated to propel the elbow replacement market in the region.

Competitive Landscape

The global players into the elbow replacement market are Integra LifeSciences Corporation, Johnson & Johnson, Lima Corporate, Ottobock SE & Co. KGaA, Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Arthritis
    • 4.2.2 Technological Advancements
    • 4.2.3 Increased Awareness of the Procedure
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternatives
    • 4.3.2 High Cost of the Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Partial Elbow Replacement
    • 5.1.2 Total Elbow Replacement
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Orthopedic Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Integra LifeSciences Corporation
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Lima Corporate
    • 6.1.4 Ottobock SE & Co. KGaA
    • 6.1.5 Stryker Corporation
    • 6.1.6 Wright Medical Group N.V.
    • 6.1.7 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS